Dynamics of regulatory T-cells during pregnancy: Effect of HIV infection and correlations with other immune parameters

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Richardson, Kelly ^a   Weinberg, Adriana ^a,b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 8; NEOPTERIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MOLECULAR DYNAMICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; THIRD TRIMESTER PREGNANCY;

ADULT; CYTOKINES; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; T-LYMPHOCYTES, REGULATORY;

EID: 82255170550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028172     Document Type: Article

References (66)

1. Adeegbe D, Bayer AL, Levy RB, Malek TR, (2006) Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 176: 7149-7153.
2. McClain MA, Gatson NN, Powell ND, Papenfuss TL, Gienapp IE, et al. (2007) Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production. J Immunol 179: 8146-8152.
3. Brooks DG, McGavern DB, Oldstone MB, (2006) Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest 116: 1675-1685.
4. Kinter AL, Horak R, Sion M, Riggin L, McNally J, et al. (2007) CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res Hum Retroviruses 23: 438-450.
5. Tovar-Salazar A, Patterson-Bartlett J, Jesser R, Weinberg A, (2010) Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells. Virology 398: 158-167.
6. Kinter A, McNally J, Riggin L, Jackson R, Roby G, et al. (2007) Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals. Proc Natl Acad Sci U S A 104: 3390-3395.
7. Cao W, Jamieson BD, Hultin LE, Hultin PM, Detels R, (2009) Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses 25: 183-191.
8. Lim A, Tan D, Price P, Kamarulzaman A, Tan HY, et al. (2007) Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. Aids 21: 1525-1534.
9. Tenorio AR, Martinson J, Pollard D, Baum L, Landay A, (2008) The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection. J Acquir Immune Defic Syndr 48: 577-580.
10. Andersson J, Boasso A, Nilsson J, Zhang R, Shire NJ, et al. (2005) The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174: 3143-3147.
11. Nixon DF, Aandahl EM, Michaelsson J, (2005) CD4+CD25+ regulatory T cells in HIV infection. Microbes and infection/Institut Pasteur 7: 1063-1065.
12. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF, (2004) Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. Journal of virology 78: 2454-2459.
13. Chase AJ, Yang HC, Zhang H, Blankson JN, Siliciano RF, (2008) Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J Virol 82: 8307-8315.
14. Kared H, Lelievre JD, Donkova-Petrini V, Aouba A, Melica G, et al. (2008) HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection. Aids 22: 2451-2460.
15. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, et al. (2005) Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 174: 4407-4414.
16. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
17. French MA, King MS, Tschampa JM, da Silva BA, Landay AL, (2009) Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells. J Infect Dis 200: 1212-1215.
18. Fahey JL, Taylor JM, Manna B, Nishanian P, Aziz N, et al. (1998) Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. Aids 12: 1581-1590.
19. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
20. Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, et al. (2010) Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. Aids 24: 1509-1517.
21. Kalayjian RC, Machekano RN, Rizk N, Robbins GK, Gandhi RT, et al. (2010) Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis 201: 1796-1805.
22. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140.
23. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, et al. (2008) Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 5: e203.
24. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, et al. (2010) Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 201: 1788-1795.
25. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, et al. (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283-2296.
26. Weinberg A, Song LY, Walker R, Allende M, Fenton T, et al. (2010) Anti-Influenza Serum and Mucosal Antibody Responses After Administration of Live Attenuated or Inactivated Influenza Vaccines to HIV-Infected Children. J Acquir Immune Defic Syndr.
27. Burns DN, Nourjah P, Wright DJ, Minkoff H, Landesman S, et al. (1999) Changes in immune activation markers during pregnancy and postpartum. J Reprod Immunol 42: 147-165.
28. Mikyas Y, Aziz N, Harawa N, Gorre M, Neagos N, et al. (1997) Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol 33: 157-170.
29. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT, (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 112: 38-43.
30. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, et al. (2005) Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166: 811-822.
31. Aluvihare VR, Kallikourdis M, Betz AG, (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5: 266-271.
32. Brettle RP, Raab GM, Ross A, Fielding KL, Gore SM, et al. (1995) HIV infection in women: immunological markers and the influence of pregnancy. Aids 9: 1177-1184.
33. Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, et al. (2005) Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 366: 1182-1188.
34. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL, (1995) CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy-induced immune depression in uninfected and HIV-infected women. J Infect Dis 172: 1221-1227.
35. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T, (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339: 285-291.
36. Dubicke A, Fransson E, Centini G, Andersson E, Bystrom B,et al. Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. J Reprod Immunol 84: 176-185.
37. El-Bastawissi AY, Williams MA, Riley DE, Hitti J, Krieger JN, (2000) Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet Gynecol 95: 1056-1064.
38. Georgiou HM, Thio YS, Russell C, Permezel M, Heng YJ, et al. (2011) Association between maternal serum cytokine profiles at 7-10 weeks' gestation and birthweight in small for gestational age infants. Am J Obstet Gynecol.
39. Goldenberg RL, Goepfert AR, Ramsey PS, (2005) Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol 192: S36-46.
40. Gomez-Lopez N, Laresgoiti-Servitje E, Olson DM, Estrada-Gutierrez G, Vadillo-Ortega F. The role of chemokines in term and premature rupture of the fetal membranes: a review. Biol Reprod 82: 809-814.
41. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, et al. (2007) The role of inflammation and infection in preterm birth. Semin Reprod Med 25: 21-39.
42. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, et al. (2009) Systemic increase in the ratio between Foxp3+ and IL-17-producing Cd4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 183: 7023-7030.
43. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, et al. (2009) Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 16: 1176-1186.
44. Aandahl EM, Quigley MF, Moretto WJ, Moll M, Gonzalez VD, et al. (2004) Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood 104: 3672-3678.
45. Epple HJ, Loddenkemper C, Kunkel D, Troger H, Maul J, et al. (2006) Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108: 3072-3078.
46. Kolte L, Gaardbo JC, Karlsson I, Sorensen AL, Ryder LP, et al. (2011) Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women. Blood 117: 1861-1868.
47. Montes M, Sanchez C, Lewis DE, Graviss EA, Seas C, et al. (2011) Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy. The Journal of infectious diseases 203: 496-499.
48. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, et al. (1996) Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106: 127-133.
49. Wegmann TG, Lin H, Guilbert L, Mosmann TR, (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14: 353-356.
50. Maier CL, Pober JS, (2011) Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses. Arteriosclerosis, Thrombosis & Vascular Biology 31: 183-189.
51. Wang W-J, Hao C-F, Qu Q-L, Wang X, Qiu L-H, et al. (2010) The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Human Reproduction 25: 2591-2596.
52. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, et al. (2007) A pivotal role for galectin-1 in fetomaternal tolerance. Nature medicine 13: 1450-1457.
53. Blois SM, Joachim R, Kandil J, Margni R, Tometten M, et al. (2004) Depletion of CD8+ cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. Journal of immunology 172: 5893-5899.
54. Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, et al. (2006) Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. Aids 20: 1823-1831.
55. Kumar RM, Uduman SA, Khurranna AK, (1995) Impact of maternal HIV-1 infection on perinatal outcome. Int J Gynaecol Obstet 49: 137-143.
56. Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, et al. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. J Infect Dis 201: 1035-1044.
57. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ, (2006) Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 193: 1195-1201.
58. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, et al. (2009) Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 200: 1068-1077.
59. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, et al. (2002) Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 347: 26-34.
60. Chikuma S, Bluestone JA, (2003) CTLA-4 and tolerance: the biochemical point of view. Immunologic research 28: 241-253.
61. Jain N, Nguyen H, Chambers C, Kang J, (2010) Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 107: 1524-1528.
62. Boasso A, Hardy AW, Anderson SA, Dolan MJ, Shearer GM, (2008) HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation. PLoS One 3: e2961.
63. Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, et al. (2009) Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 200: 973-983.
64. Sharma D, Singh A, Trivedi SS, Bhattacharjee J, (2011) Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: a pilot study in a North Indian population. Human immunology 72: 436-439.
65. Hebisch G, Grauaug AA, Neumaier-Wagner PM, Stallmach T, Huch A, et al. (2001) The relationship between cervical dilatation, interleukin-6 and interleukin-8 during term labor. Acta Obstet Gynecol Scand 80: 840-848.
66. Kramer MS, Kahn SR, Platt RW, Genest J, Chen MF, et al. Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth. Cytokine 49: 10-14.